Evaluation of a Soluble Fibrin Assay in Patients with Suspected Pulmonary Embolism

Summary

In order to determine the clinical utility of an enzyme immunoassay (EIA) for soluble fibrin in patients with suspected pulmonary embolism (PE), 195 unselected patients with suspected PE underwent blood sampling for measurement of plasma levels of soluble fibrin, and objective testing for PE. A soluble fibrin result of ≤ 0.75 Μg/ml showed a sensitivity of 100% for PE and a specificity of 12.8%, whereas a soluble fibrin result of ≤ 1.35 Μg/ml showed a sensitivity of 90.3% and a specificity of 49.4% for PE. The soluble fibrin assay has potential clinical utility in excluding PE.

• References

• 1 Bell WR, Simon TL, De Mets DL. The clinical features of submassive and massive pulmonary embolism. Am J Med 1977; 62: 355-360
• 2 The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990; 263 (20) 2753-2759
• 3 Hull RD, Hirsh J, Carter CJ, Jay RM, Dodd PE, Ockelford PA, Coates G, Gill GJ, Turpie AG, Doyle DJ, Buller HR, Raskob GE. Pulmonary angiography, ventilation lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 1983; 98: 891-899
• 4 Bounameaux H, Slosman D, de Moerloose P, Reber G. Laboratory diagnosis of pulmonary embolism: value of increased levels of plasma D-dimer and thrombin-antithrombin III complexes. Biomed Pharmacother 1989; 43: 385-388
• 5 Bridey F, Philipotteau C, Dreyfus M, Simonneau G. Plasma D-Dimer and pulmonary embolism. Lancet 1989; 1: 791-792
• 6 Speiser W, Leitha T, Dudczak R, Lechner K. Letter to the editor. Lancet 1989; 1: 792
• 7 Goldhaber SZ, Vaughan DE, Tumeh SS, Loscalzo J. Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. Am Heart J 1988; 116: 505-508
• 8 Bounameaux H, Cirafici P, de Moerloose P, Schneider PA, Slosman D, Reber G, Unger PF. Measurement of D-dimer as diagnostic aid in suspected pulmonary embolism. Lancet 1991; 337: 196-200
• 9 Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1988; 59: 101-106
• 10 Rowbotham BJ, Carrol P, Whitaker AN, Bunce IH, Colcroft RG, Elms ME, Masci PP, Bundesen PG, Rylatt DB, Webber AJ. Measurement of crosslinked fibrin derivates-use in the diagnostic of venous thrombosis. Thromb Haemost 1987; 57: 59-61
• 11 Bounameaux H, Schneider PA, Reber G, de Moerloose P, Krahenbuhl B. Measurement of plasma D-Dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol 1989; 91: 82-85
• 12 Demers C, Ginsberg JS, Johnston M, Brill-Edwards P, Panju A. D-dimer and thrombin-antithrombin III complexes in patients with clinically suspected pulmonary embolism. Thromb Haemost 1992; 67: 408-412
• 13 Heaton DC, Billings JD, Hickton CM. Assessment of D-dimer assays for the diagnosis of deep venous thrombosis. J Lab Clin Med 1987; 110: 588-591
• 14 Ginsberg JS, Brill-Edwards P, Demers C, Donovan D, Panju A. D-dimer in patients with clinically suspected pulmonary embolism. Chest 1993; 104: 1679-1684
• 15 Heijboer H, Ginsberg JS, Buller HR, Lensing AWA, Colly LP, ten Cate JW. The use of the D-dimer test in combination with non-invasive testing versus serial non-invasive testing alone for the diagnosis of deep-vein thrombosis. Thromb Haemost 1992; 67: 510-513
• 16 Brenner B, Pery M, Lanir N, Jabbarin A, Kraftori JK, Gaitini D, Rylatt D. Application of SimpliRED D-dimer in the diagnosis of deep vein thrombosis. Thromb Haemost 1993; 69: 832-1042a
• 17 Shaukat N, Rowlands DJ, Cotter L, Walker MG, Douglas JT. The specificity and sensitivity of various Elisa methods for fibrin degradation products in the diagnosis of arterial and venous thrombosis. Thromb Haemost 1993; 69: 839-1065a
• 18 Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994; 71: 1-6
• 19 John MA, Elms MJ, O’Reilly EJ, Rylatt DB, Bundesen PG, Hillyard CJ. The simpliRED D-dimer test: a novel assay for the detection of crosslinked fibrin degradation products in whole blood. Thromb Res 1990; 58: 273-281
• 20 Ginsberg JS, Wells PS, Brill-Edwards P, Donovan D, Panju AA, Patel MA. Application of a novel and rapid whole blood assay for D-dimer in patients with clinically suspected pulmonary embolism. Thromb Haemost 1995; 73: 35-38
• 21 Wells PS, Brill-Edwards P, Stevens P, Panju A, Patel A, Douketis J, Massi-cotte MPR, Hirsh J, Weitz JI, Kearon C, Ginsberg JS. A novel and rapid whole blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation 1995; 91: 2184-2187
• 22 Prins MH, Hirsh J. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. Arch Intern Med 1991; 151: 1721-1731
• 23 Gaffney P. The occurrence and clinical relevance of fibrin fragments in blood. Ann NY Acad Sc 1988; 408: 407-423
• 24 Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Shen C, Newcomer LM, Goldhaber SZ, Hennekens CH. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Circulation 1992; 85 (05) 1822-1827
• 25 Levi M, Lensing AWA, Büller HR, Prandoni P, Dooijewaard G, Cuppini S, ten Cate JW. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release. Thromb Haemost 1991; 66 (04) 426-429
• 26 Grimaudo V, Bachmann F, Hauert J, Christe MA, Kruithof EKO. Hypo-fibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism. Thromb Haemost 1992; 67 (04) 397-401
• 27 Harboume T, O’Brien D, Nicolaides AN. Fibrinolytic activity in patients with idiopathic and secondary deep vein thrombosis. Throm Res 1991; 64: 543-550
• 28 Sasaki T, Page IH, Shainoff JR. Soluble complex of fibrinogen and fibrin. Science 1966; 152: 1069-1071
• 29 Alkajersig N, Fletcher AP. Formation of soluble fibrin oligomers in purified system and in plasma. Biochem J 1983; 213: 75-83
• 30 Hull R, Van Aken WG, Hirsh J, Gallus AS, Hoicka G, Turpie AGG, Walker IR, Gent M. Impedance plethysmography using the occlusive cuff technique in the diagnosis of venous thrombosis. Circulation 1976; 53: 696-700
• 31 Hull RD, Raskob GE, Ginsberg JS, Panju AA, Brill-Edwards P, Coates G, Pineo GF. A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med 1994; 154: 289-297
• 32 Schielen WJG, Adams HPHM, van Leuven K, Voskuilen M, Tesser GI, Nieuwenhuizen W. The sequence gamma-(312-324) is a fibrin specific epitope. Blood 1991; 77: 2169-2173
• 33 Rylatt DB, Blake AS, Cottis LE, Massinham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bune I, Webber AJ, Wyatt D, Bundesen PG. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-778
• 34 Dinh D, Bolitho J, Bundesen P, Hillyard C, Marsh N, Moore B, Bottenus R, Rylatt D. Detection of soluble fibrin by enzyme immunoassay. Fibrinolysis (abs) 1994; 8: 25
• 35 Simels DL, Samsas GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991; 44: 763-770
• 36 Ginsberg JS, Siragusa S, Douketis J, Johnston M, Moffat K, Stevens P, Brill-Edwards P, Panju A, Patel A. Evaluation of a soluble fibrin assay in patients with suspected deep vein thrombosis. Thromb Haemost 1995; 74: 833-836
• 37 Dempfle CE, Dolmann M, Lill H, Muhlhofer W, Dessauer A, Henne DL. Activation parameters of blood coagulation in medical and surgical patients developing DVT: evaluation of a new fibrin monomer ELISA. Thromb Haemost 1993; 69: 1004-1649a
• 38 Hansson PO, Eriksson H, Eriksson E, Jagenburg R, Lukes P, Risberg B. Can laboratory testing improve screening strategies for deep vein thrombosis at an emergency unit?. J Inter Med 1994; 235: 143-151